Encapsulating peritoneal sclerosis: An unpredictable and devastating complication of peritoneal dialysis

American Journal of Kidney Diseases

Volumn 47, Issue 4, 2006, Pages 697-712

  Chin, Andrew I ^b   Yeun, Jane Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Ascites; Encapsulating peritoneal sclerosis; Encapsulating sclerosing peritonitis; End stage renal disease (ESRD); Epidemiology; Inflammation; Peritoneal dialysis; Peritoneal fibrosis; Peritoneal sclerosis; Sclerosing encapsulating peritonitis

Indexed keywords

PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY; LABORATORY TEST; LAPAROSCOPY; MALE; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; SCLEROSING PERITONITIS; TOTAL PARENTERAL NUTRITION;

ADULT; HUMANS; MALE; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; RISK FACTORS; SCLEROSIS;

EID: 33645220422     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.12.049     Document Type: Article

References (96)

1. V.C. Gandhi, H.M. Humayun, T.S. Ing Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Intern Med 140 1980 1201 1203
2. Y. Kawaguchi, H. Kawanishi, S. Mujais, N. Topley, D.G. Oreopoulos International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis Encapsulating peritoneal sclerosis Definition, etiology, diagnosis, and treatment Perit Dial Int 20 suppl 4 2000 S43 S55
3. H. Kawanishi, Y. Kawaguchi, H. Fukui Encapsulating peritoneal sclerosis in Japan A prospective, controlled, multicenter study Am J Kidney Dis 44 2004 729 737
4. Y. Nomoto, Y. Kawaguchi, H. Kubo, H. Hirano, S. Sakai, K. Kurokawa Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group Am J Kidney Dis 28 1996 420 427
5. R.J. Rigby, C.M. Hawley Sclerosing peritonitis The experience in Australia Nephrol Dial Transplant 13 1998 154 159
6. H. Nakamoto, Y. Kawaguchi, H. Suzuki Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan Adv Perit Dial 18 2002 119 123
7. I.E. Afthentopoulos, P. Passadakis, D.G. Oreopoulos, J. Bargman Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients One center's experience and review of the literature Adv Ren Replace Ther 5 1998 157 167
8. B.S. Kim, H.Y. Choi, D.R. Ryu Clinical characteristics of dialysis related sclerosing encapsulating peritonitis Multi-center experience in Korea Yonsei Med J 46 2005 104 111
9. H. Yamamoto, M. Nakayama, R. Yamamoto Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis A single-center experience in Japan Adv Perit Dial 18 2002 135 138
10. R. Oules, S. Challah, F.P. Brunner Case-control study to determine the cause of sclerosing peritoneal disease Nephrol Dial Transplant 3 1988 66 69
11. T. Sawada, Y. Ishii, T. Tojimbara, I. Nakajima, S. Fuchinoue, S. Teraoka The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice Pharmacol Res 46 2002 505 510
12. H. Io, C. Hamada, Y. Ro, Y. Ito, I. Hirahara, Y. Tomino Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models Kidney Int 65 2004 1927 1936
13. I. Hirahara, Y. Ogawa, E. Kusano, Y. Asano Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats Nephrol Dial Transplant 19 2004 1732 1741
14. P. Brown, H. Baddeley, A.E. Read, J.D. Davies, J. McGarry Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol) Lancet 2 1974 1477 1481
15. H.Y. Lee, B.S. Kim, H.Y. Choi Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea Nephrology (Carlton) 8 suppl 2 2003 S33 S39
16. R. Yamamoto, M. Nakayama, T. Hasegawa High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Adv Perit Dial 18 2002 131 134
17. M. Moriishi, H. Kawanishi, T. Kawai Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis Adv Perit Dial 18 2002 149 153
18. R. Yamamoto, Y. Otsuka, M. Nakayama Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment Clin Exp Nephrol 9 2005 148 152
19. J.W. Dobbie New concepts in molecular biology and ultrastructural pathology of the peritoneum Their significance for peritoneal dialysis Am J Kidney Dis 15 1990 97 109
20. J.W. Dobbie, J.K. Lloyd Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant Perit Dial Int 9 1989 215 219
21. J.W. Dobbie, T. Pavlina, J. Lloyd, R.C. Johnson Phosphatidylcholine synthesis by peritoneal mesothelium Its implications for peritoneal dialysis Am J Kidney Dis 12 1988 31 36
22. H. Kawanishi Encapsulating peritoneal sclerosis Nephrology (Carlton) 10 2005 249 255
23. N. Jonjic, G. Peri, S. Bernasconi Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells J Exp Med 176 1992 1165 1174
24. L. Lanfrancone, D. Boraschi, P. Ghiara Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1 Blood 80 1992 2835 2842
25. H. Ha, M.K. Cha, H.N. Choi, H.B. Lee Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells Perit Dial Int 22 2002 171 177
26. N. Topley, J.D. Williams Effect of peritoneal dialysis on cytokine production by peritoneal cells Blood Purif 14 1996 188 197
27. S. Ogata, N. Yorioka, N. Kohno Glucose and prednisolone alter basic fibroblast growth factor expression in peritoneal mesothelial cells and fibroblasts J Am Soc Nephrol 12 2001 2787 2796
28. R.A. Mactier The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis Adv Perit Dial 16 2000 223 228
29. Y. Masunaga, S. Muto, S. Asakura Ascites from patients with encapsulating peritoneal sclerosis augments NIH/3T3 fibroblast proliferation Ther Apher Dial 7 2003 486 493
30. S. Nakamura, T. Niwa Advanced glycation end-products and peritoneal sclerosis Semin Nephrol 24 2004 502 505
31. R. Inagi, T. Miyata, T. Yamamoto Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis FEBS Lett 463 1999 260 264
32. B. Rippe, O. Simonsen, G. Stelin Clinical implications of a three-pore model of peritoneal transport Adv Perit Dial 7 1991 3 9
33. B. Rippe, G. Stelin, B. Haraldsson Computer simulations of peritoneal fluid transport in CAPD Kidney Int 40 1991 315 325
34. O. Heimburger, J. Waniewski, A. Werynski, A. Tranaeus, B. Lindholm Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity Kidney Int 38 1990 495 506
35. W. Smit, A. Parikova, D.G. Struijk, R.T. Krediet The difference in causes of early and late ultrafiltration failure in peritoneal dialysis Perit Dial Int 25 suppl 3 2005 S41 S45
36. T. Yamamoto, T. Izumotani, T. Otoshi, M. Kim Morphological studies of mesothelial cells in CAPD effluent and their clinical significance Am J Kidney Dis 32 1998 946 952
37. G. Garosi, N. Di Paolo Peritoneal sclerosis One or two nosological entities? Semin Dial 13 2000 297 308
38. J.W. Dobbie Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis Perit Dial Int 12 1992 14 27
39. L. Gotloib, V. Wajsbrot, A. Shostak Osmotic agents hamper mesothelial repopulation as seen in the doughnut in vivo model Perit Dial Int 25 suppl 3 2005 S26 S30
40. M. Numata, M. Nakayama, S. Nimura, M. Kawakami, B. Lindholm, Y. Kawaguchi Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate Perit Dial Int 23 2003 116 122
41. M.A. Mateijsen, A.C. van der Wal, P.M. Hendriks Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis Perit Dial Int 19 1999 517 525
42. J.D. Williams, K.J. Craig, N. Topley Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 13 2002 470 479
43. S. Combet, T. Miyata, P. Moulin, D. Pouthier, E. Goffin, O. Devuyst Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis J Am Soc Nephrol 11 2000 717 728
44. P.J. Margetts, P. Bonniaud Basic mechanisms and clinical implications of peritoneal fibrosis Perit Dial Int 23 2003 530 541
45. G. Schoenicke, R. Diamant, A. Donner, A. Roehrborn, B. Grabensee, J. Plum Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis Relation to peritoneal transport Am J Kidney Dis 44 2004 146 154
46. E. Goffin, S. Combet, F. Jamar, J.P. Cosyns, O. Devuyst Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport Am J Kidney Dis 33 1999 383 388
47. M.C. Monquil, A.L. Imholz, D.G. Struijk, R.T. Krediet Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 15 1995 42 48
48. F. Perfumo, P. Altieri, M.L. Degl'Innocenti Effects of peritoneal effluents on mesothelial cells in culture Cell proliferation and extracellular matrix regulation Nephrol Dial Transplant 11 1996 1803 1809
49. S.J. Davies, L. Phillips, P.F. Naish, G.I. Russell Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis J Am Soc Nephrol 12 2001 1046 1051
50. V.M. Monnier, D.R. Sell, R.H. Nagaraj Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia Diabetes 41 suppl 2 1992 S36 S41
51. K. Honda, K. Nitta, S. Horita Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration Nephrol Dial Transplant 14 1999 1541 1549
52. S. Nakamura, S. Miyazaki, S. Sakai, T. Morita, Y. Hirasawa, T. Niwa Localization of imidazolone in the peritoneum of CAPD patients A factor for a loss of ultrafiltration Am J Kidney Dis 38 suppl 1 2001 S107 S110
53. D.H. Kang, Y.S. Hong, H.J. Lim, J.H. Choi, D.S. Han, K.I. Yoon High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells Effect of cytokine costimulation Perit Dial Int 19 1999 221 230
54. A.S. De Vriese, S. Mortier, N.H. Lameire What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 21 suppl 3 2001 S9 S18
55. H. Nakamoto, H. Imai, Y. Ishida New animal models for encapsulating peritoneal sclerosis-Role of acidic solution Perit Dial Int 21 suppl 3 2001 S349 S353
56. G. Garosi, N. Di Paolo Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis Adv Perit Dial 16 2000 204 207
57. S. Levine, A. Saltzman Abdominal cocoon An animal model for a complication of peritoneal dialysis Perit Dial Int 16 1996 613 616
58. K. Honda, K. Nitta, S. Horita Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients Adv Perit Dial 19 2003 169 175
59. T.R. Evrenkaya, E.M. Atasoyu, S. Unver, C. Basekim, H. Baloglu, M.Y. Tulbek Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 19 2004 2423 2424
60. H. Imai, H. Nakamoto, R. Fukushima, Y. Ishida, Y. Yamanouchi, H. Suzuki Role of adhesion molecules in the progression of peritoneal sclerosis Adv Perit Dial 19 2003 180 185
61. R. Pecoits-Filho, M.R. Araujo, B. Lindholm Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate Nephrol Dial Transplant 17 2002 1480 1486
62. S.H. Chung, O. Heimburger, P. Stenvinkel, J. Bergstrom, B. Lindholm Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis Nephrol Dial Transplant 16 2001 2240 2245
63. M. Numata, M. Nakayama, T. Hosoya Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients Clin Nephrol 62 2004 455 460
64. S.B. Jenkins, B.L. Leng, J.R. Shortland, P.W. Brown, M.E. Wilkie Sclerosing encapsulating peritonitis A case series from a single U.K. center during a 10-year period Adv Perit Dial 17 2001 191 195
65. A. Slingeneyer Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis Contrib Nephrol 57 1987 239 247
66. E. Lacson Jr, N.W. Levin C-Reactive protein and end-stage renal disease Semin Dial 17 2004 438 448
67. P. Stenvinkel Inflammation in end-stage renal disease-A fire that burns within Contrib Nephrol 149 2005 185 199
68. C. Zoccali, G. Enia, G. Tripepi, V. Panuccio, F. Mallamaci Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients Perit Dial Int 25 suppl 3 2005 S84 S87
69. V. Menon, T. Greene, X. Wang C-Reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease Kidney Int 68 2005 766 772
70. S. Campbell, P. Clarke, C. Hawley Sclerosing peritonitis Identification of diagnostic, clinical, and radiological features Am J Kidney Dis 24 1994 819 825
71. A.S. Hollman, M.A. McMillan, J.D. Briggs, B.J. Junor, P. Morley Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis Clin Radiol 43 1991 176 179
72. A. Korzets, Z. Korzets, G. Peer Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen Am J Nephrol 8 1988 143 146
73. D.B. Stafford-Johnson, T.E. Wilson, I.R. Francis, R. Swartz CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis J Comput Assist Tomogr 22 1998 295 299
74. G.P. Krestin, G. Kacl, M. Hauser, G. Keusch, H.R. Burger, R. Hoffmann Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease Abdom Imaging 20 1995 414 420
75. H. Kawanishi Surgical treatment for encapsulating peritoneal sclerosis Adv Perit Dial 18 2002 139 143
76. D.S. Kittur, S.W. Korpe, R.E. Raytch, G.W. Smith Surgical aspects of sclerosing encapsulating peritonitis Arch Surg 125 1990 1626 1628
77. R. Pusateri, R. Ross, R. Marshall, J.H. Meredith, R.W. Hamilton Sclerosing encapsulating peritonitis Report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature Am J Kidney Dis 8 1986 56 60
78. S. Kuriyama, H. Tomonari Corticosteroid therapy in encapsulating peritoneal sclerosis Nephrol Dial Transplant 16 2001 1304 1305
79. H. Imai, H. Nakamoto, R. Fucshima, Y. Yamanouchi, Y. Ishida, H. Suzuki Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis Adv Perit Dial 18 2002 124 130
80. S. Bhandari, A. Wilkinson, L. Sellars Sclerosing peritonitis Value of immunosuppression prior to surgery Nephrol Dial Transplant 9 1994 436 437
81. B.J. Junor, M.A. McMillan Immunosuppression in sclerosing peritonitis Adv Perit Dial 9 1993 187 189
82. V.D. Bowers, J.R. Ackermann, W. Richardson, L.C. Carey Sclerosing peritonitis Clin Transplant 8 1994 369 372
83. C.M. Hawley, D.R. Wall, D.W. Johnson Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis Am J Kidney Dis 26 1995 658 661
84. T. Dejagere, P. Evenepoel, K. Claes, D. Kuypers, B. Maes, Y. Vanrenterghem Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient Am J Kidney Dis 45 2005 e33 e37
85. R. Rajani, J. Smyth, C.G. Koffman, I. Abbs, D.J. Goldsmith Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis Nephrol Dial Transplant 17 2002 2278 2280
86. G. del Peso, M.A. Bajo, F. Gil Clinical experience with tamoxifen in peritoneal fibrosing syndromes Adv Perit Dial 19 2003 32 35
87. L. Smith, J.F. Collins, M. Morris, R.L. Teele Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis Surgical management Am J Kidney Dis 29 1997 456 460
88. K. Yamagata, C. Tomida, A. Koyama Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients Perit Dial Int 19 1999 131 137
89. M. Nakayama, H. Yamamoto, M. Ikeda Risk factors and preventive measures for encapsulating peritoneal sclerosis-Jikei experience 2002 Adv Perit Dial 18 2002 144 148
90. V. Yao, C. Platell, J.C. Hall Lavage enhances the production of proinflammatory mediators by peritoneal mesothelial cells in an experimental model Dis Colon Rectum 48 2005 560 566
91. J.A. Sjoland, R. Smith Pedersen, J. Jespersen, J. Gram Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients Nephrol Dial Transplant 19 2004 1264 1268
92. S. Mizuiri, S. Miyata, K. Sakai Effect of intraperitoneal administration of heparin on advanced glycation end-products in CAPD Perit Dial Int 19 1999 361 365
93. H. Suga, S. Teraoka, K. Ota Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats Exp Toxicol Pathol 47 1995 287 291
94. K.Y. Hung, C.T. Chen, C.J. Yen, P.H. Lee, T.J. Tsai, B.S. Hsieh Dipyridamole inhibits PDGF-stimulated human peritoneal mesothelial cell proliferation Kidney Int 60 2001 872 881
95. Y. Masunaga, S. Asakura, S. Muto Multimeric vitronectin in ascites is involved in fibroblast spreading of EPS in patients on CAPD therapy Clin Exp Nephrol 7 2003 150 156
96. K.Y. Hung, J.W. Huang, C.T. Chen, P.H. Lee, T.J. Tsai Pentoxifylline modulates intracellular signalling of TGF-beta in cultured human peritoneal mesothelial cells Implications for prevention of encapsulating peritoneal sclerosis Nephrol Dial Transplant 18 2003 670 676